AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,421,000 | +106.7% | 70,264 | +0.2% | 0.00% | +100.0% |
Q2 2020 | $1,171,000 | +19.5% | 70,107 | +3.1% | 0.00% | 0.0% |
Q1 2020 | $980,000 | -57.4% | 67,968 | -1.1% | 0.00% | -50.0% |
Q4 2019 | $2,301,000 | +58.7% | 68,736 | -0.7% | 0.00% | +33.3% |
Q3 2019 | $1,450,000 | +1.8% | 69,230 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $1,424,000 | -5.6% | 68,403 | +1.3% | 0.00% | 0.0% |
Q1 2019 | $1,509,000 | -7.9% | 67,517 | -1.5% | 0.00% | -25.0% |
Q4 2018 | $1,639,000 | -9.3% | 68,517 | +3.4% | 0.00% | 0.0% |
Q3 2018 | $1,807,000 | +1.4% | 66,248 | -0.0% | 0.00% | 0.0% |
Q2 2018 | $1,782,000 | +3.4% | 66,272 | +22.4% | 0.00% | 0.0% |
Q1 2018 | $1,723,000 | -17.9% | 54,145 | -2.4% | 0.00% | 0.0% |
Q4 2017 | $2,098,000 | +49.5% | 55,470 | -2.0% | 0.00% | +33.3% |
Q3 2017 | $1,403,000 | +9.5% | 56,597 | -9.2% | 0.00% | 0.0% |
Q2 2017 | $1,281,000 | +13.8% | 62,315 | +20.3% | 0.00% | +50.0% |
Q1 2017 | $1,126,000 | +1.5% | 51,815 | -4.4% | 0.00% | 0.0% |
Q4 2016 | $1,109,000 | +33.1% | 54,215 | -2.3% | 0.00% | 0.0% |
Q3 2016 | $833,000 | +39.8% | 55,515 | +0.7% | 0.00% | +100.0% |
Q2 2016 | $596,000 | +86.8% | 55,115 | +133.9% | 0.00% | 0.0% |
Q1 2016 | $319,000 | -16.1% | 23,560 | +14.4% | 0.00% | 0.0% |
Q4 2015 | $380,000 | -26.1% | 20,593 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $514,000 | – | 20,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |